Search research articles
Contact Us
Filters
Showing results (81-90 of 138) with videos related to
Page
of 14
Sort By:
Annals of Gastroenterology
|
May 5, 2017
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study
Alessandra Mangia, Graham R Foster, Christoph P Berg, et al.
Frontiers in Immunology
|
July 5, 2022
Liver Fibrosis in Primary Sjögren's Syndrome
Theodoros Androutsakos, Theodoros A Voulgaris, Athanasios-Dimitrios Bakasis, et al.
JMIR Research Protocols
|
February 1, 2020
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys
Giota Touloumi, Argiro Karakosta, Vana Sypsa, et al.
Antiviral Therapy
|
June 27, 2007
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring
Emanuel K Manesis, Maria Schina, Frédéric Le Gal, et al.
Pharmacological Reports : PR
|
February 29, 2016
Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population
Emma Gbandi, Antonis Goulas, Vassilios Sevastianos, et al.
Digestive Diseases (Basel, Switzerland)
|
July 10, 2019
Comparison of the Uptake of Screening Colonoscopy between Physicians and the General Population in Greece
Nikos Viazis, Maria Tzouvala, Angeliki Theodoropoulou, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial
Tarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
Annals of Gastroenterology
|
October 2, 2015
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
Spilios Manolakopoulos, Hariklia Kranidioti, John Goulis, et al.
Gastroenterology
|
September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis B
Edward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
Medical Sciences (Basel, Switzerland)
|
May 27, 2026
Evaluation of Sarcopenic Obesity in Patients with MASLD
Niki G Mourelatou, Triada Bali, Magdalini Adamantou, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 138) with videos related to
Sort By:
Page
of 14
Annals of Gastroenterology
|
May 5, 2017
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study
Alessandra Mangia, Graham R Foster, Christoph P Berg, et al.
Frontiers in Immunology
|
July 5, 2022
Liver Fibrosis in Primary Sjögren's Syndrome
Theodoros Androutsakos, Theodoros A Voulgaris, Athanasios-Dimitrios Bakasis, et al.
JMIR Research Protocols
|
February 1, 2020
Design and Development of a Viral Hepatitis and HIV Infection Screening Program (Hprolipsis) for the General, Greek Roma, and Migrant Populations of Greece: Protocol for Three Cross-Sectional Health Examination Surveys
Giota Touloumi, Argiro Karakosta, Vana Sypsa, et al.
Antiviral Therapy
|
June 27, 2007
Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring
Emanuel K Manesis, Maria Schina, Frédéric Le Gal, et al.
Pharmacological Reports : PR
|
February 29, 2016
Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population
Emma Gbandi, Antonis Goulas, Vassilios Sevastianos, et al.
Digestive Diseases (Basel, Switzerland)
|
July 10, 2019
Comparison of the Uptake of Screening Colonoscopy between Physicians and the General Population in Greece
Nikos Viazis, Maria Tzouvala, Angeliki Theodoropoulou, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial
Tarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
Annals of Gastroenterology
|
October 2, 2015
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience
Spilios Manolakopoulos, Hariklia Kranidioti, John Goulis, et al.
Gastroenterology
|
September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis B
Edward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
Medical Sciences (Basel, Switzerland)
|
May 27, 2026
Evaluation of Sarcopenic Obesity in Patients with MASLD
Niki G Mourelatou, Triada Bali, Magdalini Adamantou, et al.
Page
of 14